RECORDATI GROUP clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   Post-Authorisation Safety Study Patient Registry · Neuroblastoma…Post-Authorisation Safety Study Patient Registry · Neuroblastoma Being Treated With Dinutuximab Beta

   Primary completion pushed from Mar 31, 2032 to Jun 30, 2036

   Also in this update: Enrollment closed, study ongoing; Study completion pushed from Jun 15, 2032 to Jun 30, 2036

   RECORDATI GROUP·Not specified· NCT04253015· Registry history of NCT04253015 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

2. Notable

   PASIPHY · Pasireotide s.c. · Post-Bariatric Hypoglycaemia

   Primary and study completion pushed from Apr 2026 to Oct 29, 2026

   RECORDATI GROUP·Phase 2· NCT05928390· Registry history of NCT05928390 on ClinicalTrials.gov (opens the registry)

   Updated Sep 17, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.